| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |